We’re sharing some interesting research results that we seen in the news recently.
We’ve been hearing a lot of discussion in the news lately about textured implants and their link to a rare form of lymphoma; a cancer now known as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Recently, Health Canada moved to suspend these implants from being used in Canada.
Are you looking for a clinical trial but not sure how to start or where to go? A new Clinical Trials Finder has been developed by Clinical Trials Ontario (CTO) to help you. You can search for a clinical trial in any province or territory in Canada, using only a few simple search terms.
Vitamins are tiny organic compounds with a massive impact on your general health and well-being. Vitamins can be obtained from your daily diet, or they can be sourced from the sun (only vitamin D). More so, they have a say in almost each and every aspect of the digestive system. The best part is that as essential as they are, your body only requires them in small amounts.
Women living with breast cancer are not just cancer patients; they’re moms, spouses, sisters, friends, and daughters. The many roles and responsibilities a woman assumes to support those around her don’t disappear when she is diagnosed with cancer. One of these responsibilities may be caring for aging parents or family members. This burden may seem heavy at times but there are places you can turn to for support. Check out the following resources.
In Part 1 we discussed the risk factors of lymphedema and tips for reducing this risk. Today we’re helping you identify early signs and what treatments are available for lymphedema.
Breast cancer-related lymphedema is abnormal swelling that can develop in the arm, hand, breast, or torso on the side treated for breast cancer where lymph nodes have been removed. Lymphedema can develop suddenly or gradually. It can happen soon after surgery or can develop months or years later.
Canada’s new food guide is, in one word, refreshing! First off, it makes us hungry just looking at it. And secondly, it does away with the confusing portion sizes and focuses more on practical tips for incorporating healthier foods into our diets.
It’s just the start of 2019 but we’re already thinking about fall and the federal election it brings with it. Last year, there was a lot of talk about the establishment of a national pharmacare plan. The federal government assembled a working group to study the best way a system like this would work in Canada.
February is here, which means Valentine’s Day is around the corner. Valentine’s is a day that you either love or hate. And throwing the C-word into the mix can make it hard even when it’s something you’re usually excited for.
Last month, we had the opportunity to attend the 2018 San Antonio Breast Cancer Symposium (SABCS). Here’s some of the key highlights to come out of the conference.
Last month, we connected with Alan from ODANO, the Oncology Drug Access Navigators of Ontario, to answer a few questions about who they are and how they help patients in Ontario access life-saving medications.
That’s what Dr. Majumder and her team of researchers at Brandon University in Manitoba are hoping to find out. Dr. Majumder, Assistant Professor in Cancer Genetics and Cell Biology, is screening blood plasma from breast cancer patients and patients who don’t have breast cancer to determine if there is a blood biomarker like micro RNA (miRNA) that could potentially tell us when breast cancer is present or growing in a person.
Inflammatory breast cancer (IBC) is a rare and aggressive form of the disease that doesn’t get a lot of attention. It’s tough to diagnose because of its unusual symptoms, and it’s more common in young women which makes it particularly tricky since the symptoms mimic that of mastitis, a common breast infection in new moms who breastfeed. Here’s what you need to know:
People have known about breast cancer since ancient times. For most of that time, there were no effective treatments. However, in the last 120 years, advances in surgical and medical treatments have meant that today, 98 percent of patients with localized breast cancer survive at least five years after diagnosis. The following timeline shows the development of breast cancer treatments.
Biosimilar drug development involves many of the same steps that a biologic drug goes through but with a different focus.
Meditation programs are popping up across Canada – and for good reason. This centuries-old practice, also known as mindfulness, is one of the best tools for our health, well-being, and happiness. Research shows a daily meditation practice reduces stress, depression, and inflammation while improving sleep, fatigue, and menopausal symptoms in women who have a breast cancer diagnosis. Additionally, studies connect meditation and an enhanced immune function. These are all important considerations when you’ve had a breast cancer diagnosis.
Biosimilar therapies have already been in use in Canada for a few years, mostly in the chronic disease and supportive care settings. But soon they will be used for treating cancer as well. There isn’t a lot of information about these new oncology biosimilars and it’s important that breast cancer patients are aware of how their treatment plans may be impacted by these new therapies. We explore some of the emerging biosimilar therapies that will be used to treat cancer patients soon.
We are all familiar with generics. The exact copy of the known chemical formula used in the original medicine is what constitutes the generic form of any medicine. There are multiple reasons why generics are able to be mass produced at a lower cost. An important step includes manufacturers of generics having to provide proof that their version is an exact copy of the chemical formula of the original medicine and that when used in healthy individuals, the metabolism remains very similar to the original compound. This shortened pathway of getting approved from Health Canada or a similar regulatory agency ensures less economic burden to manufacturers and provides the obvious advantage of a significantly lower price, as well as improved accessibility for patients.
Earlier this month, the annual meeting for the American Society of Clinical Oncology was held in Chicago. Here, key research developments in every area of cancer care are shared with oncology professionals from around the world. We’ve compiled the top breast cancer highlights to come out of this year’s ASCO 2018 conference: